On Tuesday, a vaccine obtained regulatory approval after less than two months of human testing.
But experts had to express their considerations about Russia’s speed, and a developing list of countries expressed skepticism.
Scientists in Germany, France, Spain and the United States should be cautious.
“It turns out that our foreign colleagues feel the explicit competitive benefits of the Russian drug and review explicit criticism that Array … they are probably unfounded,” Russian Health Minister Mikhail Murashko told Interfax news firm on Wednesday.
He added that the vaccine would be available soon.
“The first packs of the medical vaccine matrix … will be won in the next two weeks, basically for the doctors,” Murashko said.
Russian officials have announced plans to begin mass vaccination in October.
Tuesday’s announcement was made through President Vladimir Putin, who said the vaccine had passed all the required controls and that his daughter had already won it.
But the World Health Organization (WHO) said so in talks with the Russian government to adopt a review of the vaccine, which he named Sputnik-V.
It is on the organization of the six vaccines that have reached phase 3 of clinical trials, involving more widespread human testing.
Russia’s progress in a coronavirus vaccine has been met with skepticism through fitness and media in the United States and Europe.
On Wednesday, Germany’s fitness minister expressed fear that it would have been well-tested.
“It can be harmful to start vaccinating millionsArray … to others too soon, because it may almost annihilate acceptance of vaccination if it doesn’t go well,” Jens Spahn told local media.
“Based on everything we knowArray … this hasn’t been tested enough,” he added. “It’s not about being the first one one or another, it’s about having a vaccine.”
Elsewhere in Europe, Isabelle Imbert, a researcher at the French National Centre for Scientific Research in Marseille, said promising a cure too soon can be “very dangerous.”
“We don’t know the method or effects of their clinical trials,” he told Le Parisien.
And in the United States, the country’s top virus expert, Dr. Anthony Fauci, doubted Russia’s claims.
“I hope the Russians have definitively shown that the vaccine is effective,” he told National Geographic. “I seriously doubt they did that.”
Meanwhile, the Moscow-based Association of Clinical Trial Organizations (Act), which represents the world’s leading pharmaceutical corporations in Russia, suggested to the Ministry of Health to postpone approval until the end of the Phase Three trials.
Acto Executive Director Svetlana Zavidova told Russian online MedPortal that a mass vaccination resolution was taken after a combination of first and second phase tests in 76 people, and that it was to verify the effectiveness of a drug on that basis.
But some countries reacted more resolutely to Moscow’s announcement.
In the Philippines, President Rodrigo Duterte himself proposed the vaccine.
“I think the vaccine you produced is smart for humanity,” he said. “I’ll be the first to have experience.”
And Israel said it would start negotiations to buy it if it turned out to be a “serious product.”
Russian scientists said the first trials of the vaccine were over and the effects were a success.
The Russian vaccine uses adapted strains of adenovirus, a virus that causes colds, to provoke an immune response.
But approval of the vaccine through Russian regulators comes before the final touch of a larger trial involving thousands of people, known as the phase three trial.
Experts that these tests are an essential component of the testing process.
Despite this, Murashko said Tuesday that the vaccine had “proven to be very effective and safe,” and called it a major step toward the “victory of humanity” over Covid-19.
Russia has equated vaccine studies with the race of the disputed area across the Soviet Union and the United States during the Cold War.
Russia has already been charged across the UK, US and Canada with re-searches for loans similar to Covid-19.
More than one hundred international vaccines are being developed, some of which are being tested with others in clinical trials.
Despite immediate progress, top experts that no vaccines will be available until mid-2021.